Literature DB >> 10508524

The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8.

S Ranta1, Y Zhang, B Ross, L Lonka, E Takkunen, A Messer, J Sharp, R Wheeler, K Kusumi, S Mole, W Liu, M B Soares, M F Bonaldo, A Hirvasniemi, A de la Chapelle, T C Gilliam, A E Lehesjoki.   

Abstract

The neuronal ceroid lipofuscinoses (NCLs) are a genetically heterogeneous group of progressive neurodegenerative disorders characterized by the accumulation of autofluorescent lipopigment in various tissues. Progressive epilepsy with mental retardation (EPMR, MIM 600143) was recently recognized as a new NCL subtype (CLN8). It is an autosomal recessive disorder characterized by onset of generalized seizures between 5 and 10 years, and subsequent progressive mental retardation. Here we report the positional cloning of a novel gene, CLN8, which is mutated in EPMR. It encodes a putative transmembrane protein. EPMR patients were homozygous for a missense mutation (70C-->G, R24G) that was not found in homozygosity in 433 controls. We also cloned the mouse Cln8 sequence. It displays 82% nucleotide identity with CLN8, conservation of the codon harbouring the human mutation and is localized to the same region as the motor neuron degeneration mouse, mnd, a naturally occurring mouse NCL (ref. 4). In mnd/mnd mice, we identified a homozygous 1-bp insertion (267-268insC, codon 90) predicting a frameshift and a truncated protein. Our data demonstrate that mutations in these orthologous genes underlie NCL phenotypes in human and mouse, and represent the first description of the molecular basis of a naturally occurring animal model for NCL.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508524     DOI: 10.1038/13868

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  67 in total

Review 1.  Genetics of childhood epilepsy.

Authors:  R Robinson; M Gardiner
Journal:  Arch Dis Child       Date:  2000-02       Impact factor: 3.791

2.  A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays.

Authors:  T Pastinen; M Raitio; K Lindroos; P Tainola; L Peltonen; A C Syvänen
Journal:  Genome Res       Date:  2000-07       Impact factor: 9.043

Review 3.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

4.  [NCL in animal models].

Authors:  K Rüther
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

5.  A CLN6-CLN8 complex recruits lysosomal enzymes at the ER for Golgi transfer.

Authors:  Lakshya Bajaj; Jaiprakash Sharma; Alberto di Ronza; Pengcheng Zhang; Aiden Eblimit; Rituraj Pal; Dany Roman; John R Collette; Clarissa Booth; Kevin T Chang; Richard N Sifers; Sung Y Jung; Jill M Weimer; Rui Chen; Randy W Schekman; Marco Sardiello
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

6.  2002 William Allen Award address. Introductory speech for Albert de la Chapelle.

Authors:  Janet D Rowley
Journal:  Am J Hum Genet       Date:  2003-02       Impact factor: 11.025

Review 7.  Progressive myoclonic epilepsies: review of clinical, molecular and therapeutic aspects.

Authors:  Luis Felipe Mendonça de Siqueira
Journal:  J Neurol       Date:  2010-07-01       Impact factor: 4.849

Review 8.  Cathepsin deficiency as a model for neuronal ceroid lipofuscinoses.

Authors:  John J Shacka; Kevin A Roth
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

Review 9.  Canine neuronal ceroid lipofuscinoses: Promising models for preclinical testing of therapeutic interventions.

Authors:  Martin L Katz; Eline Rustad; Grace O Robinson; Rebecca E H Whiting; Jeffrey T Student; Joan R Coates; Kristina Narfstrom
Journal:  Neurobiol Dis       Date:  2017-08-30       Impact factor: 5.996

10.  A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration.

Authors:  David E Sleat; Jennifer A Wiseman; Mukarram El-Banna; Kwi-Hye Kim; Qinwen Mao; Sandy Price; Shannon L Macauley; Richard L Sidman; Michael M Shen; Qi Zhao; Marco A Passini; Beverly L Davidson; Gregory R Stewart; Peter Lobel
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.